학술논문
P3.06-002 ATLANTIS Trial: Phase III Study of PM01183/Doxorubicin vs. CAV or Topotecan in SCLC after One Platinum-Containing Line: Topic: Clinical Studies
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology January 2017 12(1) Supplement:S1425-S1425
Subject
Language
ISSN
1556-0864